ENGLEWOOD, Colo., Nov. 15,
2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an
innovative medical technology company specializing in the
manufacture and sale of non-invasive medical devices for pain
management, rehabilitation, and patient monitoring, today
announced the Company has been ranked within Forbes' list of
America's Most Successful Small-Cap Companies for 2024. The 2024
Forbes list of America's Most Successful Small-Cap Companies can be
found at www.forbes.com.
"We are honored to be included in Forbes' Most Successful
Small-Cap Companies list for the fourth year in a row,"
said Thomas Sandgaard, CEO of Zynex. "We believe our emphasis
on providing non-invasive patient solutions leads to consistent
revenue and profitability growth that will allow Zynex to become
the world's premier pain management provider."
The data used to analyze the companies on the list was compiled
from FactSet. Forbes screened over 1,000 small cap
companies and narrowed the list down to 389 of which had positive
sales growth over the past twelve months and a share price of at
least $5. The rankings are based on many factors, including
earnings growth, sales growth, return on equity, and total stock
return for the trailing twelve months and over the last five
About Zynex, Inc.
Zynex, founded in 1996, develops,
manufactures, markets, and sells medical devices used for pain
management and rehabilitation as well as non-invasive fluid,
sepsis, and laser-based pulse oximetry monitoring systems for use
in hospitals. For additional information, please
Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
+949 694 9594
View original content to download